Century Therapeutics, Inc. (IPSC)

NASDAQ: IPSC · Real-Time Price · USD

2.140

-0.030 (-1.38%)

At close: Aug 26, 2026, 4:00 PM EDT

2.135

-0.005 (-0.23%)

After-hours: Aug 26, 2026, 7:30 PM EDT

Century Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	49.64	61.85	58.44	47.32	84.27	56.45
Short-Term Investments	70.07	55.26	130.85	125.41	231.23	166.43
Cash & Short-Term Investments	119.71	117.11	189.29	172.74	315.5	222.88
Cash Growth	-23.18%	-38.13%	9.58%	-45.25%	41.56%	194.22%
Other Receivables	1.48	0.67	1.52	2.24	0.78	0.25
Receivables	1.48	0.67	1.52	2.24	0.78	0.25
Prepaid Expenses	3.58	0.52	1.53	0.76	1.45	1.61
Restricted Cash	-	0.8	-	-	-	-
Other Current Assets	-	1.67	1.71	1.26	1.99	3.42
Total Current Assets	124.77	120.77	194.05	176.99	319.72	228.15
Property, Plant & Equipment	48	66.17	90.85	92.08	111.73	69.82
Long-Term Investments	77.48	-	30.82	89.1	51.85	135.91
Other Intangible Assets	34.2	34.2	34.2	-	-	-
Other Long-Term Assets	2.57	2.57	3.3	2.52	3.24	3.49
Total Assets	287.01	223.7	353.22	360.69	486.54	437.38

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	4.82	4.77	3.08	2.74	5.45	7.6
Accrued Expenses	6.21	8.35	12.59	8.64	9.37	5.43
Current Portion of Long-Term Debt	-	-	-	-	6.5	1.04
Current Portion of Leases	4.04	3.32	4.87	1.51	0.48	0.62
Current Unearned Revenue	-	-	109.16	4.37	7.15	-
Other Current Liabilities	-	3.78	0.08	0.58	0.87	0.98
Total Current Liabilities	15.07	20.23	129.78	17.85	29.82	15.66
Long-Term Debt	-	-	-	-	3.74	8.9
Long-Term Leases	34.63	40.24	48.96	46.66	38.7	14.56
Long-Term Unearned Revenue	-	-	-	111.38	110.83	-
Long-Term Deferred Tax Liabilities	4.3	4.3	4.37	-	-	-
Other Long-Term Liabilities	0.67	-	8.74	0.06	0.72	2.02
Total Liabilities	54.66	64.77	191.85	175.94	183.81	41.14

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,081	950.81	943.37	840.41	824.29	785.05
Retained Earnings	-848.11	-791.92	-782.34	-655.77	-519.1	-388.17
Comprehensive Income & Other	-0.69	0.03	0.32	0.11	-2.46	-0.65
Total Common Equity	232.35	158.94	161.36	184.75	302.74	396.24
Shareholders' Equity	232.35	158.94	161.36	184.75	302.74	396.24
Total Liabilities & Equity	287.01	223.7	353.22	360.69	486.54	437.38

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	38.67	43.57	53.83	48.17	49.41	25.12
Net Cash (Debt)	81.05	73.55	135.46	124.57	266.08	197.76
Net Cash Growth	-22.34%	-45.70%	8.75%	-53.19%	34.55%	264.89%
Net Cash Per Share	0.57	0.85	1.72	2.10	4.61	6.11
Filing Date Shares Outstanding	181.08	179.72	86.05	64.82	59.17	58.82
Total Common Shares Outstanding	180.55	87.52	85.84	60.34	58.47	55.01
Working Capital	109.7	100.54	64.27	159.15	289.9	212.5
Book Value Per Share	1.29	1.82	1.88	3.06	5.18	7.20
Tangible Book Value	198.15	124.74	127.16	184.75	302.74	396.24
Tangible Book Value Per Share	1.10	1.43	1.48	3.06	5.18	7.20
Machinery	27.3	33.92	33.61	30.66	30.36	19.47
Construction In Progress	0.55	0.11	0.1	0.12	14	32.84
Leasehold Improvements	47.21	61.65	61.58	60.86	48.95	8.37

SEC Filings: 10-K · 10-Q